Pilot study of erlotinib in patients with acute myeloid leukemia
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference11 articles.
1. Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison;Boehrer;Biochem Pharmacol,2008
2. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study;Boehrer;Blood,2008
3. Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia;Boehrer;Cell Cycle,2011
4. Erlotinib antagonizes ABC transporters in acute myeloid leukemia;Lainey;Cell Cycle,2012
5. SYK regulates mTOR signaling in AML;Carnevale;Leukemia,2013
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells;Cancer Research;2023-12-14
2. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes;Frontiers in Immunology;2023-11-22
3. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells;Frontiers in Oncology;2021-09-28
4. Is the EGFR pathway relevant for the pathogenesis but not for treatment of acute myeloid leukemia?;Journal of Cancer Metastasis and Treatment;2021
5. Erlotinib is effective against FLT3‐ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn;The FASEB Journal;2020-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3